Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
BioStem Technologies, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
BSEM
Nasdaq
2834
biostemtechnologies.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for BioStem Technologies, Inc.
BioStem Technologies Secures Up to $40 Million in a Committed Equity Facility
- Sep 18th, 2026 5:00 am
BioStem Technologies Opens Hospital Access for VENDAJEĀ® and VENDAJE ACĀ® Through Vizient and Premier
- Sep 4th, 2026 5:00 am
BioStem Technologies Eyes Surgical Growth, Manufacturing Shift After BioTissue Deal
- Aug 21st, 2026 7:01 pm
Sidoti Events, LLC's August Micro-Cap Virtual Conference
- Aug 18th, 2026 8:00 am
BioStem Technologies to Present at the Sidoti MicroCap Conference
- Aug 14th, 2026 2:05 pm
BioStem Technologies Inc (BSEM) (Q2 2026) Earnings Call Highlights: Revenue Surges to $7. ...
- Aug 12th, 2026 11:03 pm
BioStem Technologies Q2 Earnings Call Highlights
- Aug 12th, 2026 10:04 pm
BioStem Technologies, Inc. (BSEM) Reports Q2 Loss, Beats Revenue Estimates
- Aug 12th, 2026 3:40 pm
BioStem Technologies Reports Second Quarter 2026 Financial Results
- Aug 12th, 2026 2:05 pm
Codexis (CDXS) Reports Q2 Loss, Tops Revenue Estimates
- Aug 11th, 2026 3:45 pm
BioStem Technologies Announces Nasdaq Uplisting
- Aug 6th, 2026 3:38 pm
Novavax (NVAX) Reports Q2 Loss, Tops Revenue Estimates
- Aug 6th, 2026 7:50 am
BioStem Technologies to Host Second Quarter 2026 Financial Results Conference Call on August 12, 2026
- Jul 29th, 2026 2:05 pm
BioStem Technologies Publicly Files Form 10 Registration Statement with the Securities and Exchange Commission
- Jul 10th, 2026 5:00 am
BioStem Technologies Announces Issuance of Four U.S. Design Patents Covering Fenestrated Human Placental Allograft Technologies
- Jul 8th, 2026 6:00 am
BioStem Technologies to Present at the Planet MicroCap Las Vegas 2026 Conference
- Jun 10th, 2026 2:05 pm
BioStem Technologies Expands Board with Three Appointments as Nasdaq Uplisting Remains a Key Objective (BSEM)
- Jun 9th, 2026 8:50 am
BioStem Technologies Announces Appointment of Three New Members to its Board of Directors
- Jun 9th, 2026 5:00 am
Scroll